4 Tissue Typing Laboratory of the Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark 5 Department of Rheumatology, Gentofte University Hospital, Copenhagen, Denmark ...

1 Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands 2 Department of Rheumatology and Clinical Immunology, ...

Axial spondyloarthritis (axSpA) encompasses both radiographic and non-radiographic axSpA. It is a chronic inflammatory disease with a predilection for involving the axial skeleton. The most common ...

Objectives To develop a score for assessment of patients' symptoms in primary Sjögren's syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain, somatic and mental fatigue ...

Objective In 2011, the American College of Rheumatology (ACR) and EULAR endorsed provisional criteria for remission in rheumatoid arthritis (RA), both Boolean-based and index-based. Based on recent ...

Background Despite treatment according to the current management recommendations, a significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These patients can be ...

A taskforce comprised of an expert group of 21 rheumatologists, radiologists and methodologists from 11 countries developed evidence-based recommendations on the use of imaging in the clinical ...

1 Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands 2 Department of Rheumatology, University Medical Centre Nijmegen, The Netherlands 3 Department of Rheumatology, Leiden ...

1 Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria 2 2nd Department of Medicine, Hietzing Hospital Vienna, Vienna, Austria 3 Department of Rheumatology ...

Objective To assess the efficacy/safety of tofacitinib in adult patients with active ankylosing spondylitis (AS). Methods This phase III, randomised, double-blind, placebo-controlled study enrolled ...

Study of the genetics of rheumatoid arthritis (RA) began about four decades ago with the discovery of HLA-DRB1. Since the beginning of this century, a number of non-HLA risk loci have been identified ...